APWA
AGRX

Atlas Private Wealth Advisors’s Agile Therapeutics AGRX Stock Holding History

Atlas Private Wealth Advisors’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1
Closed -$2K – 752
2021
Q3 		$2K Hold
1
– – ﹤0.01% 687
2021
Q2 		$3K Hold
1
– – ﹤0.01% 652
2021
Q1 		$5K Hold
1
– – ﹤0.01% 633
2020
Q4 		$7K Hold
1
– – ﹤0.01% 481
2020
Q3 		$8K Hold
1
– – 0.01% 425
2020
Q2 		$7K Buy
+1
New +$5.2K 0.01% 468

Other funds holding AGRX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Atlas Private Wealth Advisors's AGRX Position: Q4 2021 in Review

Atlas Private Wealth Advisors sold out of Agile Therapeutics (AGRX) in Q4 2021, closing a stake of 1 share — an estimated $2K sold.

Atlas Private Wealth Advisors first reported a position in AGRX in Q2 2020 and held it in 6 quarters. The position peaked at $8K in Q3 2020. 45 funds tracked by Wall St. Rank hold AGRX as of Q4 2021.

  • Atlas Private Wealth Advisors reported no remaining Agile Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Atlas Private Wealth Advisors sold 1 Agile Therapeutics share in Q4 2021, an estimated $2K.
  • Atlas Private Wealth Advisors first reported a position in Agile Therapeutics in Q2 2020 and held it in 6 quarters.
  • Atlas Private Wealth Advisors's Agile Therapeutics position peaked at $8K in Q3 2020.
  • 45 funds tracked by Wall St. Rank held Agile Therapeutics as of Q4 2021.

Based on Atlas Private Wealth Advisors's 13F filing for Q4 2021, filed 21 Apr 2022.